Offerings // Cellectar Biosciences, Inc.

CLRB offering history

Every offering-related filing in Cellectar Biosciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Nov 7, 2011.

Last executed offering

May 8, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

May 29, 2026

S-1/A — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 2, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 1, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 29, 2026	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 19, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
May 8, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 6, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 20, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 10, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 2, 2025	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 1, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 30, 2025	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 26, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 5, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 7, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 6, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 29, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jul 23, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 22, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 24, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 31, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 30, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 25, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Oct 5, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 8, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 5, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 2, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 23, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 25, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 24, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 20, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 1, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 1, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 21, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 28, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 23, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 20, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 11, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 4, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)

CLRB offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CLRB workspace →

CLRB offering FAQ

When did CLRB last execute an offering?

Per SEC filings, Cellectar Biosciences, Inc.'s most recent priced offering document is a 8-K filed 2026-05-08. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CLRB last announce or register an offering?

The most recent registration is a S-1/A filed 2026-05-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.